Fundamentals screen · refreshed after the Nov 12, 2026 close
Fastest revenue growth: Healthcare
Larger companies growing quarterly revenue the fastest year over year. Latest quarter's revenue compared with the same quarter a year earlier.
| # | Company | Price | Revenue YoY | Quarterly revenue | Gross margin | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | NRIXNurix TherapeuticsHealthcare | $15.60 | +8426.3% | $673.1M | 100.0% | $1.70B |
| 2 | PTGXProtagonist TherapeuticsHealthcare | $134.38 | +5723.6% | $274.4M | 99.6% | $8.77B |
| 3 | PGENPrecigenHealthcare | $4.66 | +2437.6% | $74.1M | 91.2% | $1.67B |
| 4 | ZYMEZymeworksHealthcare | $26.47 | +828.7% | $256.5M | 100.0% | $1.86B |
| 5 | XNCRXencorHealthcare | $38.13 | +454.9% | $116.5M | 100.0% | $2.86B |
| 6 | AGIOAgios PharmaceuticalsHealthcare | $31.76 | +330.0% | $55.4M | 95.4% | $1.90B |
| 7 | LQDALiquidiaHealthcare | $58.12 | +314.6% | $225.3M | 93.4% | $5.24B |
| 8 | INSMInsmedHealthcare | $118.07 | +268.4% | $524.4M | 85.1% | $25.90B |
| 9 | URGNUroGen PharmaHealthcare | $26.39 | +223.9% | $89.0M | 91.6% | $1.29B |
| 10 | BBIOBridgeBio PharmaHealthcare | $78.17 | +192.6% | $353.2M | 94.2% | $15.23B |
| 11 | ARWRArrowhead ResearchHealthcare | $47.15 | +171.0% | $75.3M | 100.0% | $6.66B |
| 12 | ETONEton PharmaceutcialsHealthcare | $61.45 | +157.9% | $57.9M | 76.5% | $1.77B |
| 13 | SNDASonida Senior LivingHealthcare | $33.16 | +114.4% | $210.2M | 100.0% | $1.63B |
| 14 | WATWatersHealthcare | $462.20 | +113.4% | $1.65B | 44.6% | $90.84B |
| 15 | IOVAIovance BiotherapeuticsHealthcare | $7.63 | +80.1% | $121.5M | 60.5% | $3.53B |
| 16 | RYTMRhythm PharmaceuticalsHealthcare | $109.86 | +79.6% | $92.1M | 86.8% | $7.62B |
| 17 | CRONCronos Group Inc. Common ShareHealthcare | $3.41 | +71.8% | $83.9M | 64.8% | $1.25B |
| 18 | PTCTPTC TherapeuticsHealthcare | $63.36 | +69.6% | $357.8M | 93.4% | $5.29B |
| 19 | CORTCorcept TherapeuticsHealthcare | $73.71 | +64.0% | $340.5M | 98.6% | $7.97B |
| 20 | TARSTarsus PharmaceuticalsHealthcare | $76.89 | +63.9% | $194.6M | 92.9% | $3.79B |
| 21 | IMAXImaxHealthcare | $47.89 | +63.7% | $174.6M | 72.4% | $2.64B |
| 22 | TGTXTG TherapeuticsHealthcare | $64.56 | +60.7% | $259.9M | 83.8% | $9.76B |
| 23 | KNSAKiniksa Pharmaceuticals InternationalHealthcare | $96.28 | +58.1% | $286.0M | 90.3% | $7.56B |
| 24 | GKOSGlaukosHealthcare | $246.03 | +58.0% | $211.0M | 85.2% | $14.56B |
| 25 | IONSIonis PharmaceuticalsHealthcare | $27.31 | +54.9% | $242.7M | 98.6% | $4.55B |
| 26 | AXSMAxsome TherapeuticsHealthcare | $144.37 | +51.9% | $259.7M | 93.1% | $7.59B |
| 27 | MDGLMadrigal PharmaceuticalsHealthcare | $425.21 | +50.1% | $431.3M | 100.0% | $9.88B |
| 28 | COHRCoherentHealthcare | $232.08 | +49.9% | $2.37B | 39.1% | $45.71B |
| 29 | ARQTArcutis BiotherapeuticsHealthcare | $27.53 | +45.1% | $143.9M | 91.3% | $3.48B |
| 30 | XERSXeris Biopharma HoldingsHealthcare | $16.65 | +44.2% | $107.2M | 88.4% | $3.04B |
| 31 | NBIXNeurocrine BiosciencesHealthcare | $169.40 | +41.2% | $1.12B | 97.6% | $17.15B |
| 32 | TMDXTransMedics GroupHealthcare | $92.00 | +41.1% | $203.0M | 58.5% | $3.20B |
| 33 | MIRMMirum PharmaceuticalsHealthcare | $93.33 | +39.6% | $185.7M | 81.1% | $6.09B |
| 34 | CDNACareDxHealthcare | $79.81 | +39.3% | $139.4M | 71.1% | $4.19B |
| 35 | HALOHalozyme TherapeuticsHealthcare | $100.67 | +39.2% | $493.0M | 83.3% | $11.48B |
| 36 | LLYEli Lilly &Healthcare | $1,427.28 | +38.6% | $24.40B | 83.9% | $1.27T |
| 37 | HROWHarrowHealthcare | $28.30 | +38.6% | $99.3M | 75.4% | $1.06B |
| 38 | HIMSHims & Hers HealthHealthcare | $19.73 | +38.2% | $753.2M | 63.8% | $4.62B |
| 39 | REGNRegeneron PharmaceuticalsHealthcare | $951.19 | +36.3% | $5.12B | 88.8% | $98.40B |
| 40 | TVTXTravere TherapeuticsHealthcare | $51.56 | +36.2% | $224.6M | 98.7% | $4.95B |
| 41 | GHGuardant HealthHealthcare | $154.86 | +36.1% | $361.0M | 65.4% | $20.95B |
| 42 | NTRANateraHealthcare | $322.94 | +34.1% | $794.0M | 64.7% | $46.83B |
| 43 | ESTAEstablishment Labs HoldingsHealthcare | $68.62 | +33.9% | $72.0M | 69.1% | $2.05B |
| 44 | BMRNBioMarin PharmaceuticalsHealthcare | $56.70 | +32.0% | $1.02B | 80.0% | $10.98B |
| 45 | PNTGThe Pennant GroupHealthcare | $35.91 | +32.0% | $302.3M | 17.9% | $1.26B |
| 46 | KRYSKrystal BiotechHealthcare | $305.68 | +30.2% | $127.3M | 94.1% | $9.06B |
| 47 | CDRECadre HoldingsHealthcare | $33.08 | +30.2% | $202.9M | 43.4% | $1.42B |
| 48 | KLACKLAHealthcare | $157.30 | +28.9% | $4.14B | 61.9% | $204.96B |
| 49 | ANIPANI PharmaceuticalsHealthcare | $71.06 | +27.6% | $290.8M | 61.6% | $1.62B |
| 50 | CAICaris Life SciencesHealthcare | $23.96 | +27.0% | $275.4M | 66.2% | $6.87B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.